Anixa Biosciences Inc
NASDAQ:ANIX
Products
Anixa Biosciences Gets FDA Clearance For Ovarian Cancer Trial
Published: 08/30/2021 12:36 GMT
Anixa Biosciences Inc (ANIX) - Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer Car-t Immunotherapy.
Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer Car-t Immunotherapy.
Anixa Biosciences Inc - Robert Wenham, Chair of Gynecological Oncology at Moffitt Will Lead Clinical Trial.
Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer Car-t Immunotherapy.
Anixa Biosciences Inc - Robert Wenham, Chair of Gynecological Oncology at Moffitt Will Lead Clinical Trial.